INVESTORS SHOULD ONLY RELY ON INFORMATION PUBLISHED BY UNIVERSAL
NETTLETON, Miss., Jan. 27 /PRNewswire-FirstCall/ -- Universal Bioenergy, Inc. (Pink Sheets: UBRG) announces that certain unauthorized inaccurate information is being published about Universal in an analyst report on BeaconEquity.com website, potentially other websites and publications, and an email spam concerning Universal.
After reviewing these materials, the company has found errors in statements concerning the company's status and capabilities. Universal Bioenergy, Inc. strongly urges potential investors to rely solely on our SEC filings or information produced directly by the company. Universal recommends investors disregard any information published by third-parties.
Universal is a developmental stage company with limited operating history. To date it has not generated any revenue. Anyone considering purchasing securities of this company should review its filings with the Securities and Exchange Commission.
'/>"/>SOURCE Universal Bioenergy, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 Related biology technology :1.
Portola Data on Its Novel Syk Inhibitors and Novel Universal Factor Xa Inhibitor Antidote to be Presented at 2008 American Society of Hematology (ASH) Meeting2.
Universal Bioenergy, Inc. Seeks Algae Feedstock Companies for Acquisition, Alliance, and Joint Venture Opportunities for Biodiesel Production3.
Carna Biosciences Signs Distribution Agreement with Shanghai Universal Biotech Company4.
[video] Jacques Tizabi, CEO of Universal Detection Technology Discusses Latest Purchase Order on WallSt.nets 3-Minute Press Show5.
New Chromatography Detectors From Varian, Inc. Extend the Range of Universal Detection for HPLC and LC/MS6.
Carrington and Universal Harvest Sign Supply Agreement7.
EDDA Technology Introduces Universal Enterprise Solution - Enabling 2D/3D/4D Advanced Clinical Applications on Existing PACS Workstations8.
SyntheMed Files Universal Shelf Registration9.
Raj Khankari Named Bioenergy, Inc., CEO10.
International Diabetes Experts Call for Stepped-Up Action and Shared Responsibility to Curb Rising Global Diabetes Epidemic and Impact11.
Global Vision Recognized for Helping Pharmaceutical Companies Achieve Complete Artwork and Copy Accuracy in their Packaging Process